ECSP951592A - SUSTAINED RELEASE CAFFEINE FORMULATION - Google Patents

SUSTAINED RELEASE CAFFEINE FORMULATION

Info

Publication number
ECSP951592A
ECSP951592A ECSP951592A ECSP951592A EC SP951592 A ECSP951592 A EC SP951592A EC SP951592 A ECSP951592 A EC SP951592A EC SP951592 A ECSP951592 A EC SP951592A
Authority
EC
Ecuador
Prior art keywords
stimulant
sustained release
composition
xanthine
matrix
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Chauffard Francoise
Robert B Mccall
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP951592 priority Critical patent/ECSP951592A/en
Publication of ECSP951592A publication Critical patent/ECSP951592A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

El invento se refiere a una composición para la liberación controlada de un estimulante de xantina o de un derivado de xantina, que contiene micropartículas que incluyen una matriz biodegradable de por lo menos un material soluble en agua y el estimulante, estando formado dicho estimulante de partículas sólidas que están sustncialmente distribuidas uniformemente a lo largo de toda la matriz.También concierne a un método para fabricar esta composición mediante la dispersión del estimulante en la forma de una variedad de partículas sólidas dentro de una matriz biodegradable ente ser administrada oralmente para incrementar el estado de alerta de un individuo.The invention relates to a composition for the controlled release of a xanthine stimulant or a xanthine derivative, containing microparticles including a biodegradable matrix of at least one water-soluble material and the stimulant, said particle stimulant being formed solids that are substantially evenly distributed throughout the entire matrix. It also concerns a method of making this composition by dispersing the stimulant in the form of a variety of solid particles within a biodegradable matrix to be administered orally to increase the status alert of an individual.

ECSP951592 1995-11-30 1995-11-30 SUSTAINED RELEASE CAFFEINE FORMULATION ECSP951592A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP951592 ECSP951592A (en) 1995-11-30 1995-11-30 SUSTAINED RELEASE CAFFEINE FORMULATION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP951592 ECSP951592A (en) 1995-11-30 1995-11-30 SUSTAINED RELEASE CAFFEINE FORMULATION

Publications (1)

Publication Number Publication Date
ECSP951592A true ECSP951592A (en) 1997-06-11

Family

ID=42042234

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP951592 ECSP951592A (en) 1995-11-30 1995-11-30 SUSTAINED RELEASE CAFFEINE FORMULATION

Country Status (1)

Country Link
EC (1) ECSP951592A (en)

Similar Documents

Publication Publication Date Title
AR002947A1 (en) COMPOSITION FOR THE CONTROLLED RELEASE OF A XANTINA STIMULANT OR XANTINA DERIVATIVE AND METHOD FOR PREPARING SUCH COMPOSITION
AR018252A1 (en) PHARMACEUTICAL DOSAGE FORM IN SOLID PARTICLES SUITABLE FOR ORAL SUPPLY.
EP2298279A3 (en) Pharmaceutical compositions for inhalation
AR012933A1 (en) A TABLET OF A COMPACT PARTICULATED CLEANING COMPOSITION AND A PROCEDURE FOR PREPARING IT.
NZ333844A (en) Compositions comprising mircoparticles of water-insoluble substances and method for preparing same
CO5261536A1 (en) MULTIPARTICULATED MODIFIED RELEASE COMPOSITION
BG105379A (en) Pharmaceutical compositions for the treatment of acute disorders
BG105573A (en) Dispersible phospholipid stabilized microparticles
IT9022155A0 (en) PHARMACEUTICAL COMPOSITIONS IN THE FORM OF PARTICLES SUITABLE FOR THE CONTROLLED RELEASE OF PHARMACOLOGICALLY ACTIVE SUBSTANCES AND PROCEDURE FOR THEIR PREPARATION
BR9916053B1 (en) compositions containing a peptide and a polylactic glycolic acid suitable for preparation of prolonged release subcutaneous implants.
DE69905380T2 (en) PHARMACEUTICAL COMPOSITIONS WITH QUICK RELEASE OF ACTIVE SUBSTANCES
WO2006085101A3 (en) Pharmaceutical compositions useful in the transmucosal administration of drugs
CY1107810T1 (en) COMPOSITIONS WHICH HAVE A COMBINATION OF IMMEDIATE LIBERATION AND CONTROLLED LIBERTY CHARACTERISTICS
MXPA05007158A (en) Pharmaceutical formulation with an insoluble active agent for pulmonary administration.
ES2191616T3 (en) PULVERIZABLE POWDER OF FLUOROPOLIMEROS NON FIBRILABLE.
DE69834195D1 (en) STABILIZED TRAMADOL FORMULATIONS WITH DELAYED RELEASE
BR0314958A (en) Multiple Photon Reactive Composition, Article and Method for Making an Organic-Inorganic Composite
AU2001263228A1 (en) Rapidly disintegrating solid oral dosage form
ES2062563T3 (en) PROCEDURE TO PREPARE A SOLID HYDROPHOBIC OR AEROPHYL DISPERSIBLE IN WATER.
BG102228A (en) Medicamentous form with controlled release of slightly soluble medicamentous substances
AR030862A1 (en) MEDICAL FORMULATIONS IN AEROSOL
PT1113787E (en) CONTROLLED LIBERATION PHARMACEUTICAL PREPARATIONS IN THE FORM OF MULTIPLE UNITS INDEPENDENT FROM THE SHAKING AND PROCESS FOR PREPARING THE SAME
HUP0100303A2 (en) Porous hydroxyapatite particles as carriers for drug substances
GB0008411D0 (en) Pharmaceutical preparations and their manufacture
ECSP951592A (en) SUSTAINED RELEASE CAFFEINE FORMULATION